Kabuki syndrome

Error creating thumbnail:

Kabuki syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and various congenital abnormalities. It was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, and it is also known as Niikawa-Kuroki syndrome.

Signs and Symptoms

Individuals with Kabuki syndrome often exhibit a range of physical and developmental characteristics, including:

• Distinctive facial features such as long eyelashes, arched eyebrows, and large, prominent ears.
• Growth retardation leading to short stature.
• Intellectual disability and developmental delays.
• Skeletal abnormalities, including scoliosis and joint hypermobility.
• Congenital heart defects.
• Hearing loss.
• Immune system abnormalities, which may lead to frequent infections.

Genetics

Kabuki syndrome is primarily caused by mutations in the KMT2D gene, which is involved in histone modification and plays a crucial role in regulating gene expression. A smaller percentage of cases are caused by mutations in the KDM6A gene. Both genes are important for normal development and function of multiple organ systems.

Diagnosis

Diagnosis of Kabuki syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the KMT2D or KDM6A genes. Early diagnosis is important for managing the various health issues associated with the syndrome.

Management

There is no cure for Kabuki syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include:

• Regular monitoring and treatment of congenital heart defects.
• Early intervention programs and special education to address developmental delays.
• Physical therapy to improve motor skills and manage skeletal abnormalities.
• Hearing aids or other interventions for hearing loss.
• Regular monitoring and treatment of immune system abnormalities.

Epidemiology

Kabuki syndrome is a rare disorder, with an estimated prevalence of 1 in 32,000 to 1 in 86,000 individuals. It affects both males and females equally and has been reported in various ethnic groups worldwide.

History

The syndrome was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, who observed a group of patients with similar facial features and developmental delays. The name "Kabuki syndrome" was chosen because the facial features of affected individuals were reminiscent of the makeup used in Kabuki theater.

See Also

• Genetic disorder
• Intellectual disability
• Congenital heart defect
• Scoliosis
• Hearing loss